Navigation Links
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
Date:7/16/2009

RESEARCH TRIANGLE PARK, N.C., July 16 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that Kenneth I. Moch has joined the company as Chief Operating Officer.

Mr. Moch brings more than 25 years of experience in managing and financing biomedical technologies, and has played a key role in building several life science companies. In this newly-created position, Mr. Moch will be responsible for overseeing corporate and financial strategy, business development and operations, reporting to George Painter, Ph.D., Chimerix's President and Chief Executive Officer.

"Ken is a seasoned industry executive whose depth and breadth of leadership experience significantly strengthens the Chimerix management team," said Dr. Painter. "I look forward to working closely with Ken on a shared vision for advancing Chimerix's pipeline of potent broad spectrum antiviral compounds, and building an organization focused on advancing important new medicines."

"With a rich pipeline of next-generation antiviral drug candidates, productive platform technology, an extraordinary library of new leads and supportive top-tier investors, Chimerix combines deep assets with the scientific heritage necessary to emerge at the forefront of antiviral drug development," said Mr. Moch. "I am excited to join this veteran team. We have the opportunity to create much-needed new pharmaceutical products with promise in a broad range of challenging viral diseases."

Prior to joining Chimerix, Mr. Moch founded Euclidean Life Science Advisors, a provider of strategic advisory services to life sciences companies, where he most recently served as President and CEO of BioMedical Enterprises, Inc., a developer and marketer of orthopaedic memory metal implants. Previously, he was Managing Director, Healthcare Investment
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Progenitor Cell Therapy Appoints VP of Manufacturing Operations
2. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
3. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
4. OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
5. Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
6. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
7. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
8. Novavax Appoints Stanley Erck to Board of Directors
9. Qforma Appoints Four Executives in Sales and Field Operations
10. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
11. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... and NEW YORK ... Inc. (NASDAQ:  PTBI), a biopharmaceutical company advancing protein ... provided an overview of the Company,s 2014 achievements ... achievements below demonstrate the progress the Company has ... multiple corporate partnerships for its MuGard programs, the ...
(Date:4/1/2015)... NEW YORK CITY and LONDON ... of market research reports and solutions, MarketResearch.com is pleased to ... will be a year of market growth and opportunity for ... stem cell company or cord blood bank, competing in the ... market conditions, predict industry trends, and act on market changes ...
(Date:4/1/2015)... Immunocore Limited ("the Company"), ... to treat cancer, viral infections and autoimmune disease, ... Christina Coughlin as Chief Medical Officer. ... and regulatory leadership to the pre-clinical and clinical ... has extensive experience in oncology drug development, with ...
(Date:3/31/2015)... 31, 2015 Eastern Kentucky University ... online bachelor’s of criminal justice degree programs by ... to inspiring ideas and high quality educational opportunities,” ... the University. We are confident that students will ... This is the site’s first “Students before Profits” ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 4EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2
... DALLAS, Texas , April ... report, ,global oncology biomarker market, published by,MarketsandMarkets ( http://www.marketsandmarkets.com ... from $4.1 billion in 2009 to ... from 2009 to 2014. The Global Oncology,Biomarkers Market report ...
... is to be conducted at Glenfield Hospital Leicester thanks ... Hospitals of Leicester. Dr Andr Ng, Senior Lecturer ... Consultant Cardiologist and Electrophysiologist, Glenfield Hospital, University Hospitals of ... carry out the operation remotely on patients using this ...
... ... full-custom SoC technology without the cost and leadtime on display at ESC Silicon Valley, ... ... embedded motion control systems, today announced its partnership with Actel Corporation (NASDAQ: ACTL) for ...
Cached Biology Technology:MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014 2MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014 3MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014 4World first remote heart operation to be carried out in Leicester using robotic arm 2World first remote heart operation to be carried out in Leicester using robotic arm 3TRINAMIC Teams with Actel's SmartFusion™ Intelligent Mixed Signal FPGAs for Motion Control 2
(Date:3/24/2015)... NexID Biometrics LLC, whose spoof-mitigation technology boosts protection ... beginning of shipments of version 2.0 of its industry ... in Potsdam, N.Y. , is making ... here today at the Walter E. Washington Convention Center. ... boosts the accuracy rate range to 96.5 to 99.5 ...
(Date:3/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... starting March 30 th . The ... New York markets. Gino ... our new ad campaign following the recent initial shipment of ...
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... LA JOLLAThe Salk Institute for Biological Studies will join ... in Stem Cell Genomics, created through a $40 million ... for Regenerative Medicine. The center will bring together ... focus on bridging the fields of genomics the ...
... joining you just moments after you poured that first ... to conduct a finely-choreographed search, one that,s been described ... of Washington.The search mission is another example of fruit ... their brains having 100,000 neurons compared to house flies ...
... a small peninsula of 11,500 km2 within the Arabian ... during the last decades, thus putting a strong pressure ... towards sustainable development has triggered a variety of studies ... project has confirmed the occurrence of 21 lizard species, ...
Cached Biology News:Salk Institute and Stanford University to lead new $40 million stem cell genomics center 2Salk Institute and Stanford University to lead new $40 million stem cell genomics center 3Fruit flies -- fermented-fruit connoisseurs -- are relentless party crashers 2Fruit flies -- fermented-fruit connoisseurs -- are relentless party crashers 3Where do lizards in Qatar live? First distribution maps for the state 2
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
... contains 4 deuterium atoms at the 9, 10, ... use as an internal standard for the quantification ... is produced by the lipoxygenation of linoleic acid ... detected in atherosclerotic plaques, as an esterified component ...
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: